Excluded studies

Excluded studies

Study reference

Reason for exclusion

Gosden TB, Dhanjal J, Arper D et al. (2017) Assessing the cost effectiveness of a new, first-in-class triple fixed dose combination therapy for COPD patients. Value in Health 20(9): A647

Abstract only

Gosden TB, Dhanjal J, Arper D et al. (2017) Budget impact of a new, first-in-class triple fixed dose combination therapy for COPD patients. Value in Health 20(9): A641

Abstract only